C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients.

Vanessa F BonazziLauren G AoudeSandra BrosdaJulia J BradfordJames M LonieKelly A LofflerMichael G GartsideKalpana PatelPamela MukhopadhyayColm KeaneVal GebskiJames G KenchDavid GoldsteinNicola WaddellAndrew P Barbournull null

Published in: Asia-Pacific journal of clinical oncology (2023)

PDAC patients with long survival have higher hENT1 expression levels. Furthermore, CRP expression is a biomarker of poor prognosis following perioperative chemotherapy and resection in PDAC patients and thus may be useful for identifying patients who could benefit from more aggressive adjuvant strategies.

Keyphrases

poor prognosis
end stage renal disease
long non coding rna
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
early stage
radiation therapy
patient reported outcomes
squamous cell carcinoma
cardiac surgery
locally advanced